Previous Article | Next Article ![]()
Mol Cell Biol, May 1998, p. 2688-2696, Vol. 18, No. 5
Laboratory of Biochemistry and Genetics,
National Institute of Diabetes and Digestive and Kidney Diseases,
Bethesda, Maryland 20892-0830
Received 3 November 1997/Returned for modification 5 January
1998/Accepted 23 February 1998
We mapped and cloned SKI6 of Saccharomyces
cerevisiae, a gene that represses the copy number of the L-A
double-stranded RNA virus, and found that it encodes an essential
246-residue protein with homology to a tRNA-processing enzyme,
RNase PH. The ski6-2 mutant expressed electroporated
non-poly(A) luciferase mRNAs 8- to 10-fold better than did the isogenic
wild type. No effect of ski6-2 on expression of uncapped or
normal mRNAs was found. Kinetics of luciferase synthesis and direct
measurement of radiolabeled electroporated mRNA indicate that the
primary effect of Ski6p was on efficiency of translation rather than on
mRNA stability. Both ski6 and ski2 mutants show
hypersensitivity to hygromycin, suggesting functional alteration of the
translation apparatus. The ski6-2 mutant has normal amounts
of 40S and 60S ribosomal subunits but accumulates a 38S particle
containing 5'-truncated 25S rRNA but no 5.8S rRNA, apparently an
incomplete or degraded 60S subunit. This suggests an abnormality in 60S
subunit assembly. The ski6-2 mutation suppresses the poor
expression of the poly(A)
0270-7306/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Ski6p Is a Homolog of RNA-Processing Enzymes That Affects
Translation of Non-Poly(A) mRNAs and 60S Ribosomal Subunit
Biogenesis

and
viral mRNA in a strain
deficient in the 60S ribosomal protein L4. Thus, a ski6
mutation bypasses the requirement of the poly(A) tail for translation,
allowing better translation of non-poly(A) mRNA, including the
L-A virus mRNA which lacks poly(A). We speculate that the
derepressed translation of non-poly(A) mRNAs is due to abnormal (but full-size) 60S subunits.
*
Corresponding author. Mailing address: Bldg. 8, Room
225, NIH, 8 Center Dr., MSC 0830, Bethesda, MD 20892-0830. Phone:
(301) 496-3452. Fax: (301) 402-0240. E-mail:
wickner{at}helix.nih.gov.
Present address: Technology Development and Commercialization
Branch, National Cancer Institute, Rockville, Md.
Present address: CBER, Food and Drug Administration, Bethesda,
Md.
This article has been cited by other articles:
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|